Zobrazeno 1 - 10
of 58 033
pro vyhledávání: '"Carbamazepine"'
Autor:
Sabet FS; Department of Nanobiotechnology, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran. Electronic address: fereshte.sabet@modares.ac.ir., Dabirmanesh B; Department of Biochemistry, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran. Electronic address: dabirmanesh@modares.ac.ir., Sabet HS; Department of Life Science Engineering, Faculty of New Sciences & Technologies, University of Tehran, Tehran, Iran. Electronic address: hoorie.sabet@ut.ac.ir., Zarei P; Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: Parisa.zareie@modares.ac.ir., Hosseini M; Department of Life Science Engineering, Faculty of New Sciences & Technologies, University of Tehran, Tehran, Iran. Electronic address: hosseini_m@ut.ac.ir., Fathollahi Y; Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: fatolahi@modares.ac.ir., Khajeh K; Department of Nanobiotechnology, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran; Department of Biochemistry, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran. Electronic address: khajeh@modares.ac.ir.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2024 Oct 25; Vol. 664, pp. 124610. Date of Electronic Publication: 2024 Aug 20.
Autor:
Sá Filho A; Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil., Martins JLR; Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil., Costa RF; Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil., Pedrino GR; Institute of Biological Sciences, Federal University of Goiás, Goiás 74605-010, GO, Brazil., Duarte VS; Structural and Theoretical Chemistry Group, State University of Goiás, Anápolis 75083-515, GO, Brazil., Silva ON; Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil., Napolitano HB; Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil.; Structural and Theoretical Chemistry Group, State University of Goiás, Anápolis 75083-515, GO, Brazil., Fajemiroye JO; Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anapolis 75083-515, GO, Brazil.; Institute of Biological Sciences, Federal University of Goiás, Goiás 74605-010, GO, Brazil.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Sep 11; Vol. 25 (18). Date of Electronic Publication: 2024 Sep 11.
Autor:
Harris K; Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Queensland Poisons Information Centre, Queensland Children's Hospital, Brisbane, Queensland, Australia., Dalton B; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Queensland Poisons Information Centre, Queensland Children's Hospital, Brisbane, Queensland, Australia., Learmont BG; Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Australia., Isoardi KZ; Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Queensland Poisons Information Centre, Queensland Children's Hospital, Brisbane, Queensland, Australia.
Publikováno v:
Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2024 Aug; Vol. 62 (8), pp. 533-535. Date of Electronic Publication: 2024 Aug 20.
Autor:
Ruscheweyh R; Neurologische Klinik und Poliklinik, LMU Klinikum, LMU München, Marchioninistr. 15, 81377, München, Deutschland. ruth.ruscheweyh@med.uni-muenchen.de., Gierthmühlen J; Interdisziplinäres Zentrum für Schmerz- und Palliativmedizin, Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Deutschland., Hedderich DM; Abteilung für Diagnostische und Interventionelle Neuroradiologie, Klinikum rechts der Isar, School of Medicine and Health, Technische Universität München, München, Deutschland., Goßrau G; Kopfschmerzambulanz, Interdisziplinäres UniversitätsSchmerzCentrum, Medizinische Fakultät, Universitätsklinikum Dresden, TU Dresden, Dresden, Deutschland., Leis S; Christian-Doppler-Klinik, Universitätsklinik für Neurologie, neurologische Intensivmedizin und Neurorehabilitation, Paracelsus Medizinische Universität, Salzburg, Österreich.
Publikováno v:
Schmerz (Berlin, Germany) [Schmerz] 2024 Aug; Vol. 38 (4), pp. 283-292. Date of Electronic Publication: 2024 Apr 30.
Autor:
Jaiprasart P; Clinical Pharmacology & Pharmacometrics, Janssen Research & Development, North Wales, PA, USA., Hellemans P; Oncology Research & Development, Janssen Research & Development, Beerse, Belgium., Jiao JJ; Statistics and Decision Science, Janssen Research & Development, Raritan, NJ, USA., Dosne AG; Clinical Pharmacology & Pharmacometrics, Janssen Research & Development, Beerse, Belgium., De Meulder M; Bioanalytical Discovery & Development Sciences, Janssen Research & Development, Beerse, Belgium., De Zwart L; Preclinical Sciences & Translational Safety, Janssen Research & Development, Beerse, Belgium., Brees L; Clinical Pharmacology Unit, Janssen Research & Development, Merksem, Belgium., Zhu W; Clinical Pharmacology & Pharmacometrics, Janssen Research & Development, Raritan, NJ, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Aug; Vol. 13 (8), pp. 852-860. Date of Electronic Publication: 2024 May 13.
Population toxicokinetics of carbamazepine and its metabolite carbamazepine-10,11-epoxide in adults.
Autor:
Lukic V; National Poison Control Centre, Military Medical Academy, Belgrade, Serbia.; Medical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia., Jankovic SM; Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.; Department of Clinical Pharmacology, University Clinical Center Kragujevac, Kragujevac, Serbia., Petrovic NZ; Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.; Department of Clinical Pharmacology, University Clinical Center Kragujevac, Kragujevac, Serbia., Vucinic S; National Poison Control Centre, Military Medical Academy, Belgrade, Serbia.; Medical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia., Jovic Stosic J; National Poison Control Centre, Military Medical Academy, Belgrade, Serbia.; Medical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia., Djordjevic S; National Poison Control Centre, Military Medical Academy, Belgrade, Serbia.; Medical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia., Dragojevic-Simić V; Medical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia.; Centre for Clinical Pharmacology, Military Medical Academy, Belgrade, Serbia.
Publikováno v:
Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2024 Aug; Vol. 20 (8), pp. 817-825. Date of Electronic Publication: 2024 Jul 21.
Autor:
Zhang X; School of Energy and Environmental Engineering, Beijing Key Laboratory of Resource-oriented Treatment of Industrial Pollutants, International Science and Technology Cooperation Base for Environmental and Energy Technology of MOST, University of Science and Technology Beijing, Beijing 100083, PR China., Zhang X; School of Energy and Environmental Engineering, Beijing Key Laboratory of Resource-oriented Treatment of Industrial Pollutants, International Science and Technology Cooperation Base for Environmental and Energy Technology of MOST, University of Science and Technology Beijing, Beijing 100083, PR China., Li H; School of Energy and Environmental Engineering, Beijing Key Laboratory of Resource-oriented Treatment of Industrial Pollutants, International Science and Technology Cooperation Base for Environmental and Energy Technology of MOST, University of Science and Technology Beijing, Beijing 100083, PR China., Ao X; School of Energy and Environmental Engineering, Beijing Key Laboratory of Resource-oriented Treatment of Industrial Pollutants, International Science and Technology Cooperation Base for Environmental and Energy Technology of MOST, University of Science and Technology Beijing, Beijing 100083, PR China., Sun W; School of Environment, Tsinghua University, Beijing 100084, China.; Research Institute for Environmental Innovation (Suzhou) Tsinghua, Suzhou 215163, China., Li Z; School of Energy and Environmental Engineering, Beijing Key Laboratory of Resource-oriented Treatment of Industrial Pollutants, International Science and Technology Cooperation Base for Environmental and Energy Technology of MOST, University of Science and Technology Beijing, Beijing 100083, PR China.
Publikováno v:
Environmental science & technology [Environ Sci Technol] 2024 Oct 22; Vol. 58 (42), pp. 19070-19079. Date of Electronic Publication: 2024 Oct 09.
Autor:
Barnard SN; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Chen Z; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Kanner AM; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Holmes MG; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Klein P; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Abou-Khalil BW; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Gidal BE; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., French J; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia., Perucca P; From the Department of Neuroscience (S.N.B., Z.C., P.P.), Central Clinical School, and Clinical Epidemiology (Z.C.), School of Public Health and Preventive Medicine, Monash University; Department of Neurology (S.N.B., Z.C., P.P.), Alfred Health, Melbourne, Australia; Department of Neurology (S.N.B., J.F.), New York University Grossman School of Medicine, New York; Department of Neurology (A.M.K.), University of Miami, Miller School of Medicine, FL; Department of Neurology (M.G.H.), Westchester Medical Center Health, Valhalla, NY; Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD; Department of Neurology (P.K.), The George Washington University, DC; Department of Neurology (B.W.A.-K.), Vanderbilt University Medical Center, Nashville, TN; School of Pharmacy (B.E.G.), University of Wisconsin, Madison; Department of Neurology (P.P.), The Royal Melbourne Hospital; Department of Medicine (P.P.), Austin Health, The University of Melbourne; and Bladin-Berkovic Comprehensive Epilepsy Program (P.P.), Department of Neurology, Austin Health, Heidelberg, Australia.
Publikováno v:
Neurology [Neurology] 2024 Oct 08; Vol. 103 (7), pp. e209821. Date of Electronic Publication: 2024 Sep 13.
Autor:
Munjal B; Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States., DeBoyace K; Pfizer Worldwide Research and Development, Drug Product Design, Groton, Connecticut 06340, United States., Cao F; Pfizer World Research & Development, Drug Product Design, San Diego, California 92121, United States., Krzyzaniak JF; Pfizer Worldwide Research and Development, Drug Product Design, Groton, Connecticut 06340, United States., Arora KK; Pfizer Worldwide Research and Development, Drug Product Design, Groton, Connecticut 06340, United States., Suryanarayanan R; Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2024 Oct 07; Vol. 21 (10), pp. 5150-5158. Date of Electronic Publication: 2024 Aug 13.
Autor:
Datta-Mannan A; Eli Lilly and Company, Indianapolis, Indiana, USA., Shanks E; Eli Lilly and Company, Bracknell, Berkshire, UK., Yuen E; Eli Lilly and Company, Bracknell, Berkshire, UK., Jin Y; Eli Lilly and Company, Indianapolis, Indiana, USA., Rehmel J; Eli Lilly and Company, Indianapolis, Indiana, USA., Hall SD; Eli Lilly and Company, Indianapolis, Indiana, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Oct; Vol. 116 (4), pp. 1034-1041. Date of Electronic Publication: 2024 Jun 12.